Joe, just my thoughts mate...
A lot depends on whether Merck is contemplating any financial transactions (takeover,licence purchase etc) re immutep..
Any commercial registration of Aipac would likely increase the price of those financial transactions..
CHECKPOINT INHIBITORS - What The?, page-17
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.8¢ |
Change
-0.003(0.89%) |
Mkt cap ! $403.6M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.5¢ | $59.27K | 212.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 264340 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 357192 | 22 |
View Market Depth
| Last trade - 11.34am 06/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |